Biodimension: A Life Sciences Startup Raises Rs 8 Crore

Biodimension, a startup in the life sciences sector located in Bengaluru, has successfully secured Rs 8 crore in a funding round spearheaded by IAN Angel Fund. The funding round also saw participation from existing investor Campus Angels Network, Dr. Sampath Srisailam, and angel investor Aaryan Baid.

The funds will be allocated to boost product development, enhance laboratory facilities, fortify scientific and commercial teams, and assist in the market introduction of its products both in India and internationally.

About Biodimension

Founded by Manojkumar S., Ranjith Kumar Velusamy, and Pradeep Arunachalam, Biodimension focuses on creating biofabricated human tissue and organoid models as substitutes for animal testing, catering to the needs of pharmaceutical, biotechnology, and cosmetic industries.

Product Portfolio

The offerings from Biodimension include BioDEpi, BioDFT, BioDPigma, a Pan-Cancer Tumour Microenvironment (TME) Biobank, and Bioassay-as-a-Service (BaaS). These products are designed to provide human-relevant testing solutions, crucial for research, safety evaluations, and drug discovery.

Collaborations and Expansion Plans

Biodimension has successfully formed partnerships with various pharmaceutical companies, biotech firms, research institutions, and contract research organisations throughout India and Singapore. The company aims to extend its oncology research capabilities, scale its Bioassay-as-a-Service platform, and explore new international markets, including Southeast Asia.